Primary Record
Motixafortide
- In stock
- 817 g
- Purity
- 99.6 %
- CAS
- 664334-36-5
Compound Identifiers & Properties
- CAS
- 664334-36-5
- PubChem CID
- 16131686
- SMILES
- C1C[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N2C1)CCCCN)CCCCN)CCCNC(=O)N)CC3=CC=C(C=C3)O)NC(=O)[C@H](CC4=CC5=CC=CC=C5C=C4)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)C6=CC=C(C=C6)F)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N)CCCNC(=O)N)CCCNC(=N)N)CC7=CC=C(C=C7)O
- Canonical SMILES
- N=C(N)NCCC[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)c2ccc(F)cc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCCNC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(N)=O)C(=O)N1)C(N)=O
Names & Synonyms
- Motixafortide
- BKT140
- BKT140 acetate salt
- 4F-benzoyl-TN14003
- Motixafortide (BL-8040)
- 664334-36-5
- orb1707544
- BKT-140
- JJVZSYKFCOBILL-KZGZZEQFSA-N
- 4F-BENZOYL-TN-14003
- GLXC-20012
- s9665
- AKOS032944983
- BL-8040
- AS-84209
- DA-61745
- J1.943.898H
- F85502
- Bz(4-F)-Arg-Arg-2Nal-Cys(1)-Tyr-Cit-Lys-D-Lys-Pro-Tyr-Arg-Cit-Cys(1)-Arg-NH2
- N2-(4-Fluorobenzoyl)-Arg-Arg-Nal-Cys-Tyr-Cit-Lys-DLys-Pro-Tyr-Arg-Cit-Cys-Arg-NH2
- (2S)-N-[(1S)-1-{[(1S)-1-{[(3S,6S,9S,12R,17R,20S,23S,26S,29R,34aS)-26,29-bis(4-aminobutyl)-12-{[(1S)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}-6-(3-carbamimidamidopropyl)-9,23-bis[3-(carbamoylamino)propyl]-3,20-bis[(4-hydroxyphenyl)methyl]-1,4,7,10,18,21,24,27,30-nonaoxo-dotriacontahydropyrrolo[2,1-p]1,2-dithia-5,8,11,14,17,20,23,26,29-nonaazacyclodotriacontan-17-yl]carbamoyl}-2-(naphthalen-2-yl)ethyl]carbamoyl}-4-carbamimidamidobutyl]-5-carbamimidamido-2-[(4-fluorophenyl)formamido]pentanamide
- (3R,6S,9S,12S,15R,20R,23S,26S,29S,32S)-3,6-bis(4-aminobutyl)-N-[(1S)-1-carbamoyl-4-guanidino-butyl]-15-[[(2S)-2-[[(2S)-2-[[(2S)-2-[(4-fluorobenzoyl)amino]-5-guanidino-pentanoyl]amino]-5-guanidino-pentanoyl]amino]-3-(2-naphthyl)propanoyl]amino]-26-(3-guanidinopropyl)-12,29-bis[(4-hydroxyphenyl)methyl]-2,5,8,11,14,22,25,28,31-nonaoxo-9,23-bis(3-ureidopropyl)-17,18-dithia-1,4,7,10,13,21,24,27,30-nonazabicyclo[30.3.0]pentatriacontane-20-carboxamide
- (3R,6S,9S,12S,15R,20R,23S,26S,29S,32S)-3,6-Bis(4-aminobutyl)-N-[(2S)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]-15-[[(2S)-2-[[(2S)-5-carbamimidamido-2-[[(2S)-5-carbamimidamido-2-[(4-fluorobenzoyl)amino]pentanoyl]amino]pentanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-26-(3-carbamimidamidopropyl)-9,23-bis[3-(carbamoylamino)propyl]-12,29-bis[(4-hydroxyphenyl)methyl]-2,5,8,11,14,22,25,28,31-nonaoxo-17,18-dithia-1,4,7,10,13,21,24,27,30-nonazabicyclo[30.3.0]pentatriacontane-20-carboxamide
- 4-Fluorobenzoyl-L-Arg-L-Arg-L-betaNal-L-Cys(1)-L-Tyr-L-Cit-L-Lys-D-Lys-L-Pro-L-Tyr-L-Arg-L-Cit-L-Cys(1)-L-Arg-NH2
- Nalpha-(4-Fluorobenzoyl)-L-Arg-L-Arg-3-(2-naphthyl)-L-Ala-L-Cys(1)-L-Tyr-L-Cit-L-Lys-D-Lys-L-Pro-L-Tyr-L-Arg-L-Cit-L-Cys(1)-Arg-NH2
- Nalpha-(4-Fluorobenzoyl)-L-Arg-L-Arg-L-betaNal-L-Cys(1)-L-Tyr-L-Cit-L-Lys-D-Lys-L-Pro-L-Tyr-L-Arg-L-Cit-L-Cys(1)-L-Arg-NH2